Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lucid Group Inc

2.53
+0.02000.80%
Post-market: 2.51-0.0200-0.79%16:09 EDT
Volume:96.89M
Turnover:248.40M
Market Cap:7.71B
PE:-2.02
High:2.62
Open:2.52
Low:2.50
Close:2.51
Loading ...

2 High-Risk, High-Reward Electric Vehicle Stocks for the Future of Transportation

Motley Fool
·
Yesterday

​​Could Buying Lucid Group Stock Today Set You Up for Life?

Motley Fool
·
Yesterday

2 Millionaire-Maker Electric Vehicle (EV) Stocks

Motley Fool
·
Yesterday

Why Lucid Group Stock Is Sinking Today

Motley Fool
·
Yesterday

Stock Track | Lucid Group (LCID) Plummets 5.27% Pre-Market Amid Ongoing Production and Financial Challenges

Stock Track
·
30 Apr

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025

PR Newswire
·
30 Apr

​​Where Will Lucid Be in 1 Year?

Motley Fool
·
30 Apr

Will Lucid Group (LCID) Report Negative Earnings Next Week? What You Should Know

Zacks
·
29 Apr

China EV Insurance Registrations for Week Ending Apr 27: Nio 6,500, Onvo 1,470, Tesla 10,280, BYD 62,200

CnEVPost
·
29 Apr

Lucid Group (LCID) Beats Stock Market Upswing: What Investors Need to Know

Zacks
·
29 Apr

EV Stocks Jump With NIO up 8%, Tesla up 3%

Tiger Newspress
·
28 Apr

Prediction: Lucid Group Will Soar in 2026. Here's 1 Reason Why.

Motley Fool
·
28 Apr

Down 20% This Year, Is Lucid Stock Finally a Buy?

Motley Fool
·
27 Apr

Better EV Stock: Lucid vs. Tesla

Motley Fool
·
26 Apr

Clean-Energy Factories Are Being Cancelled as Problems Pile Up -- Barrons.com

Dow Jones
·
26 Apr

BRIEF-NCI-Sponsored Study Shows Positive Data For Lucid Diagnostics' Esoguard® Esophageal Dna Test In Patients Without Symptomatic Gerd

Reuters
·
24 Apr

Nci-Sponsored Study Shows Positive Data for Lucid Diagnostics' Esoguard® Esophageal DNA Test in Patients Without Symptomatic Gerd

THOMSON REUTERS
·
24 Apr

NCI-Sponsored Study Shows Positive Data for Lucid Diagnostics' EsoGuard® Esophageal DNA Test in Patients Without Symptomatic GERD

PR Newswire
·
24 Apr

Here's Why Lucid Group (LCID) Gained But Lagged the Market Today

Zacks
·
23 Apr

Press Release: Quantum Biopharma Announces Advocate Against Naked Short Selling and Stock Manipulation, Kevin Malone Appointed as Board Advisor

Dow Jones
·
22 Apr